Wockhardt recalls its drugs in the US

According to the FDA, the drugs have been recalled due to due to the "failure of dissolution test observed at three month time point", the US health regulator said.

recall1-1-jpg-475x310-q85

Wockhardt recalls its hypertension drug in the US

Drug major Wockhardt has decided to recall over 8,000 bottles of anti-hypertension drug Metoprolol Succinate extended-release tablets in the US market. The decision was taken after the capsules failed a dissolution test. The bottles were manufactured by Mumbai based Wockhardt Ltd. and distributed in the US market by Wockhardt USA Inc.

The withdrawal was classified as a Class-II recall, which the FDA defines as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

 

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X